Trial · NCT04032119
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Overall procedural time | During the endoscopic procedure | From the beginning of mucosal incision till the end of submucosal dissection, excluding time for prophylactic homeostasis |
| Secondary | Number of intra-procedural hemorrhage events | During the endoscopic procedure | The number of oozing or spurting bleeding events during a procedure, requiring hemostasis with coagulating forceps |
| Secondary | Maximum systolic blood pressure | During the endoscopic procedure | Maximum systolic blood pressure during ESD |
| Secondary | Maximum heart rate | During the endoscopic procedure | Maximum heart rate during ESD |
| Secondary | Adverse event - Delayed hemorrhage | 30 days | Delayed hemorrhage (Based on CTCAE definition) |
| Secondary | Adverse event - Perforation | 30 days | Perforation (Based on CTCAE definition) |
| Secondary | Adverse event - Cardiovascular event | 30 days | Cardiovascular event (Based on CTCAE definition) |
| Secondary | Adverse event - Cerebrovascular event | 30 days | Cerebrovascular event (Based on CTCAE definition) |
| Secondary | Other adverse event | 30 days | Based on CTCAE definition |
| Secondary | Pathology | During the endoscopic procedure | Final histology based on Vienna Classification |
| Secondary | Size of lesion | During the endoscopic procedure | Size of lesion |
| Secondary | Depth of invasion | During the endoscopic procedure | Depth of tumor invasion |
| Secondary | Vertical margin | During the endoscopic procedure | Vertical margin involvement |
| Secondary | Horizontal margin | During the endoscopic procedure | Horizontal margin involvement |
| Secondary | Differentiation | During the endoscopic procedure | Degree of differentiation for cancer of stomach |
| Secondary | Lymphovascular invasion | During the endoscopic procedure | Lymphovascular invasion on pathology |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04032119/registered